Diabetic retinopathy for the non-ophthalmologist
- PMID: 35304370
- PMCID: PMC8966825
- DOI: 10.7861/clinmed.2021-0792
Diabetic retinopathy for the non-ophthalmologist
Abstract
Diabetic retinopathy is a microangiopathy resulting from the chronic effects of diabetes mellitus. Healthcare professionals often work in isolation to deliver highly specialised care efficiently and effectively for people living with diabetes. It is not uncommon for people with diabetes to be making frequent visits to community and hospital clinics to see a variety of specialists and healthcare professionals, with seemingly little opportunity for coordination of this complex health management programme between the wider team. In a field that is so diverse and rapidly changing, healthcare professionals of all specialties need to be aware of developments across all aspects of diabetes management. In this article, we discuss the epidemiology and natural history of diabetic retinopathy and describe an approach to its assessment and diagnosis. We provide an overview of the principles of diabetic retinopathy management and outline possible future treatments for diabetic retinopathy.
Keywords: diabetic macular oedema; diabetic retinopathy; intravitreal injections; laser photocoagulation; vitrectomy.
© Royal College of Physicians 2022. All rights reserved.
Figures



Similar articles
-
Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease.Eye (Lond). 2017 May;31(S1):S1-S20. doi: 10.1038/eye.2017.53. Eye (Lond). 2017. PMID: 28490797 Free PMC article.
-
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.Health Technol Assess. 2022 Dec;26(50):1-86. doi: 10.3310/SZKI2484. Health Technol Assess. 2022. PMID: 36541393 Free PMC article. Clinical Trial.
-
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.Health Technol Assess. 2021 May;25(32):1-104. doi: 10.3310/hta25320. Health Technol Assess. 2021. PMID: 34060440 Free PMC article.
-
Diabetic eye disease: A review of screening and management recommendations.Clin Exp Ophthalmol. 2021 Mar;49(2):128-145. doi: 10.1111/ceo.13894. Epub 2021 Jan 10. Clin Exp Ophthalmol. 2021. PMID: 33438363 Review.
-
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.J Diabetes Investig. 2021 Aug;12(8):1322-1325. doi: 10.1111/jdi.13480. Epub 2021 Jan 14. J Diabetes Investig. 2021. PMID: 33316144 Free PMC article. Review.
Cited by
-
The application and clinical translation of the self-evolving machine learning methods in predicting diabetic retinopathy and visualizing clinical transformation.Front Endocrinol (Lausanne). 2024 Sep 19;15:1429974. doi: 10.3389/fendo.2024.1429974. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39363895 Free PMC article.
-
Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes.World J Diabetes. 2023 May 15;14(5):585-593. doi: 10.4239/wjd.v14.i5.585. World J Diabetes. 2023. PMID: 37273250 Free PMC article. Review.
-
Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease-Interplay Between Inflammation and Oxidative Stress.Int J Mol Sci. 2024 Nov 4;25(21):11850. doi: 10.3390/ijms252111850. Int J Mol Sci. 2024. PMID: 39519401 Free PMC article. Review.
-
Prevalence and associated factors of proliferative diabetic retinopathy among adult diabetic patients in Northwest Ethiopia, 2023: A cross-sectional multicenter study.PLoS One. 2024 May 10;19(5):e0303267. doi: 10.1371/journal.pone.0303267. eCollection 2024. PLoS One. 2024. PMID: 38728350 Free PMC article.
-
Anti-Aging Potential of Avocado Oil via Its Antioxidant Effects.Pharmaceuticals (Basel). 2025 Feb 12;18(2):246. doi: 10.3390/ph18020246. Pharmaceuticals (Basel). 2025. PMID: 40006059 Free PMC article. Review.
References
-
- Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107;244–9. - PubMed
-
- GBD 2019 Blindness and Visual Impairment Collaborators . Causes of blindness and visual impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to vision 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 2021;9;e144–60. - PMC - PubMed
-
- Modjtahedi BS, Wu J, Luong TQ, et al. . Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality. Ophthalmology 2021;128;1169–79. - PubMed
-
- Diabetes Control and Complications Trial Research Group , Nathan DM, Genuth S, et al. . The effect of intensive treatment of diabetes on the development and prevention of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993;329;977–86. - PubMed
-
- Stratton IM, Kohner EM, Aldington SJ, et al. . UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44;156–63. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical